Tesamorelin peptide cycling protocols vary in research settings. Studies often evaluate 8–24 week periods to observe endocrine and metabolic markers. Long-term safety and human-use protocols are not established for research peptides.

Disclaimer: These statements are for informational purposes only and not intended to treat, diagnose, or cure any disease. All products mentioned are for research purposes only and not for human use.